Logo image
A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging
Journal article   Open access   Peer reviewed

A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging

Alyson P Black, Hongyan Liang, Connor A West, Mengjun Wang, Harmin P Herrera, Brian B Haab, Peggi M Angel, Richard R Drake and Anand S Mehta
Analytical chemistry (Washington), v 91(13), pp 8429-8435
02 Jul 2019
PMID: 31177770
url
https://europepmc.org/articles/pmc7017646View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Biomarkers - metabolism Case-Control Studies Glycomics - methods Glycoproteins - chemistry Glycoproteins - metabolism Glycosylation Humans Liver Cirrhosis - diagnosis Liver Cirrhosis - metabolism Optical Imaging - methods Polysaccharides - chemistry Polysaccharides - metabolism Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods
A new platform for N-glycoprotein analysis from serum that combines matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) workflows with antibody slide arrays is described. Antibody panel based (APB) N-glycan imaging allows for the specific capture of N-glycoproteins by antibodies on glass slides and N-glycan analysis in a protein-specific and multiplexed manner. Development of this technique has focused on characterizing two abundant and well-studied human serum glycoproteins, alpha-1-antitrypsin and immunoglobulin G. Using purified standard solutions and 1 μL samples of human serum, both glycoproteins can be immunocaptured and followed by enzymatic release of N-glycans. N-Glycans are detected with a MALDI FT-ICR mass spectrometer in a concentration-dependent manner while maintaining specificity of capture. Importantly, the N-glycans detected via slide-based antibody capture were identical to that of direct analysis of the spotted standards. As a proof of concept, this workflow was applied to patient serum samples from individuals with liver cirrhosis to accurately detect a characteristic increase in an IgG N-glycan. This novel approach to protein-specific N-glycan analysis from an antibody panel can be further expanded to include any glycoprotein for which a validated antibody exists. Additionally, this platform can be adapted for analysis of any biofluid or biological sample that can be analyzed by antibody arrays.

Metrics

22 Record Views
44 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Chemistry, Analytical
Logo image